{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:19:46Z","timestamp":1790727586150,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>\n                    The spread of drug-resistant tuberculosis strains has become a significant economic burden globally. To tackle this challenge, there is a need to develop new drugs that target specific mycobacterial enzymes. Among these enzymes, InhA, which is crucial for the survival of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    , is a key target for drug development. Herein, 24 compounds were synthesized by merging 4-carboxyquinoline with triazole motifs. These molecules were then tested for their effectiveness against different strains of tuberculosis, including\n                    <jats:italic>M. bovis BCG<\/jats:italic>\n                    ,\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    , and\n                    <jats:italic>M. abscessus<\/jats:italic>\n                    . Additionally, their ability to inhibit the InhA enzyme was also evaluated. Several molecules showed potential as inhibitors of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    . Compound\n                    <jats:bold>5n<\/jats:bold>\n                    displayed the highest efficacy with a MIC value of 12.5\u00a0\u03bcg\/mL. Compounds\n                    <jats:bold>5g<\/jats:bold>\n                    ,\n                    <jats:bold>5i<\/jats:bold>\n                    , and\n                    <jats:bold>5n<\/jats:bold>\n                    exhibited inhibitory effects on InhA. Notably,\n                    <jats:bold>5n<\/jats:bold>\n                    showed significant activity compared to the reference drug Isoniazid. Molecular docking analysis revealed interactions between these molecules and their target enzyme. Additionally, the molecular dynamic simulations confirmed the stability of the complexes formed by quinoline-triazole conjugate\n                    <jats:bold>5n<\/jats:bold>\n                    with the InhA. Finally,\n                    <jats:bold>5n<\/jats:bold>\n                    underwent\n                    <jats:italic>in silico<\/jats:italic>\n                    analysis to predict its ADME characteristics. These findings provide promising insights for developing novel small compounds that are safe and effective for the global fight against tuberculosis.\n                  <\/jats:p>","DOI":"10.3389\/fchem.2024.1424017","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T07:25:23Z","timestamp":1723015523000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity"],"prefix":"10.3389","volume":"12","author":[{"given":"Ahmed","family":"Sabt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha-Hamadien","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal S.","family":"Ebaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Pawe\u0142czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam A.","family":"Abd El Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninh The","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Xuan","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor-Ali","family":"Vaali Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer","family":"Traiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elsawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozena","family":"Dziadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Dziadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.3390\/molecules27248807","article-title":"Development of novel isatin-tethered quinolines as anti-tubercular agents against multi and extensively drug-resistant mycobacterium tuberculosis","volume":"27","author":"Abdelrahman","year":"2022","journal-title":"Molecules"},{"key":"B2","doi-asserted-by":"publisher","first-page":"114531","DOI":"10.1016\/j.ejmech.2022.114531","article-title":"Designing quinoline-isoniazid hybrids as potent anti-tubercular agents inhibiting mycolic acid biosynthesis","volume":"239","author":"Alcaraz","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jac\/dkr173","article-title":"Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs","volume":"66","author":"Almeida Da Silva","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2200133","DOI":"10.1002\/ardp.202200133","article-title":"New [1, 2, 4] triazolo [4, 3-c] quinazoline derivatives as vascular endothelial growth factor receptor\u20102 inhibitors and apoptosis inducers: design, synthesis, docking, and antiproliferative evaluation","volume":"355","author":"Azab","year":"2022","journal-title":"Arch. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"","journal-title":"Nucleic acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"","journal-title":"Nucleic acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.15167\/2421-4248\/jpmh2017.58.1.728","article-title":"The history of tuberculosis: from the first historical records to the isolation of Koch\u2019s bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J. Prev. Med. Hyg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00044-021-02716-7","article-title":"Design and synthesis of new 1, 4, 5-trisubstituted triazole-bearing benzenesulphonamide moiety as selective COX-2 inhibitors","volume":"30","author":"Bekheit","year":"2021","journal-title":"Med. Chem. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.3390\/cells10123476","article-title":"Imidazole-thiosemicarbazide derivatives as potent anti-Mycobacterium tuberculosis compounds with antibiofilm activity","volume":"10","author":"Bekier","year":"2021","journal-title":"Cells"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1021\/jm2003624","article-title":"Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain","volume":"54","author":"Boechat","year":"2011","journal-title":"J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cbdd.14060","article-title":"Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors","volume":"100","author":"Dadlani","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.thorsurg.2018.09.010","article-title":"The global fight against tuberculosis","volume":"29","author":"Daley","year":"2019","journal-title":"Surg. Clin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.7886450","article-title":"Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis","volume":"267","author":"Dessen","year":"1995","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115409","DOI":"10.1016\/j.ejmech.2023.115409","article-title":"Comprehensive coverage on anti-mycobacterial endeavour reported during 2022","volume":"255","author":"Dhameliya","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jhet.336","article-title":"Tandem Michael addition\/imino-nitrile cyclization synthesis of 2-amino-6-(1-aryl-5-methyl-1H-1,2,3-triazol-4yl)-4-phenylpyridine-3-carbonitrile","volume":"47","author":"Dong","year":"2010","journal-title":"J. Heterocycl. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2. 0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"B18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/14756366.2021.2015344","article-title":"2-Arylquinolines as novel anticancer agents with dual EGFR\/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights","volume":"37","author":"Elbadawi","year":"2022","journal-title":"J. Enzyme Inhibition Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tetlet.2015.11.070","article-title":"A simple one-pot synthesis of quinoline-4-carboxylic acids by the Pfitzinger reaction of isatin with enaminones in water","volume":"57","author":"Elghamry","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1080\/14756366.2022.2110869","article-title":"New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies","volume":"37","author":"Elkaeed","year":"2022","journal-title":"J. Enzyme Inhibition Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","article-title":"1, 5-diaryl-1, 2, 4-triazole ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities","volume":"66","author":"Elsawi","year":"2023","journal-title":"J. Med. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/ph17010081","article-title":"1, 2, 4-triazole-tethered indolinones as new cancer-fighting small molecules targeting VEGFR-2: synthesis, biological evaluations and molecular docking","volume":"17","author":"Elsawi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B23","doi-asserted-by":"publisher","first-page":"106312","DOI":"10.1016\/j.bioorg.2022.106312","article-title":"New tetrahydropyrimidine-1, 2, 3-triazole clubbed compounds: antitubercular activity and Thymidine Monophosphate Kinase (TMPKmt) inhibition","volume":"131","author":"El-Shoukrofy","year":"2023","journal-title":"Bioorg. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"20130437","DOI":"10.1098\/rstb.2013.0437","article-title":"The ongoing challenge of latent tuberculosis","volume":"369","author":"Esmail","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/jcm.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1016\/j.bmcl.2008.09.096","article-title":"Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis","volume":"18","author":"Gill","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","article-title":"Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides","volume":"15","author":"He","year":"2007","journal-title":"Bioorg Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1021\/jm060715y","article-title":"Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis","volume":"49","author":"He","year":"2006","journal-title":"J. Med. Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"a021105","DOI":"10.1101\/cshperspect.a021105","article-title":"The mycobacterial cell envelope-lipids","volume":"4","author":"Jackson","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: a promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"107138","DOI":"10.1016\/j.bioorg.2024.107138","article-title":"Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)","volume":"144","author":"Khaleel","year":"2024","journal-title":"Bioorg. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-61779-588-6_10","article-title":"Methods of protein structure comparison","volume":"857","author":"Kufareva","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e202200324","DOI":"10.1002\/cbdv.202200324","article-title":"Exploration of isoxazole\u2010carboxylic acid methyl ester based 2\u2010substituted quinoline derivatives as promising antitubercular agents","volume":"19","author":"Kumar Sahoo","year":"2022","journal-title":"Chem. Biodivers."},{"key":"B35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1568026621666211111160332","article-title":"The antibacterial activity of 1, 2, 3-triazole-and 1, 2, 4-triazole-containing hybrids against Staphylococcus aureus: an updated review (2020-present)","volume":"22","author":"Li","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/ar700156e","article-title":"Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway","volume":"41","author":"Lu","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1099\/00221287-146-2-289","article-title":"InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II","volume":"146","author":"Marrakchi","year":"2000","journal-title":"Microbiology"},{"key":"B39","first-page":"64","article-title":"2, 4-Cycloaddition reactions: preparation and cytotoxicity of novel quinoline and pyrrolo [3, 4-f] quinoline derivatives","volume":"7","author":"Mohamede","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.str.2020.12.008","article-title":"Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis","volume":"29","author":"Munir","year":"2021","journal-title":"Structure"},{"key":"B41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jctube.2017.06.001","article-title":"Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates","volume":"8","author":"Muthaiah","year":"2017","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"106904","DOI":"10.1016\/j.bioorg.2023.106904","article-title":"Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1, 2, 3-triazole-quinoline hybrid mixtures","volume":"141","author":"Nyoni","year":"2023","journal-title":"Bioorg. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1134\/s1070363209020248","article-title":"Synthesis and selected transformations of 1-(5-methyl-1-aryl-1 H-1, 2, 3-triazol-4-yl) ethanones and 1-[4-(4-R-5-methyl-1 H-1, 2, 3-triazol-1-yl) phenyl] ethanones","volume":"79","author":"Pokhodylo","year":"2009","journal-title":"Russ. J. General Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1183\/13993003.00724-2015","article-title":"Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis","volume":"47","author":"Pym","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11632","DOI":"10.3390\/ijms241411632","article-title":"Mycobacterium tuberculosis inhibitors based on arylated quinoline carboxylic acid backbones with anti-mtb gyrase activity","volume":"24","author":"Quimque","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.drudis.2016.09.009","article-title":"A new \u2018golden age\u2019for the antitubercular target InhA","volume":"22","author":"Ro\u017eman","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e202300804","DOI":"10.1002\/cbdv.202300804","article-title":"Antibacterial activity of quinoline\u2010based derivatives against methicillin\u2010resistant Staphylococcus aureus and Pseudomonas aeruginosa: design, synthesis, DFT and molecular dynamic simulations","volume":"20","author":"Sabt","year":"","journal-title":"Chem. Biodivers."},{"key":"B50","doi-asserted-by":"publisher","first-page":"114959","DOI":"10.1016\/j.ejmech.2022.114959","article-title":"New antileishmanial quinoline linked isatin derivatives targeting DHFR-TS and PTR1: design, synthesis, and molecular modeling studies","volume":"246","author":"Sabt","year":"","journal-title":"Eur. J. Med. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"111843","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B52","first-page":"956","article-title":"Synthesis, characterization and antimicrobial activity of somequinoline appended 1, 2, 3-triazoles","volume":"92","author":"Senthil","year":"2015","journal-title":"J. INDIAN Chem. Soc."},{"key":"B53","doi-asserted-by":"publisher","first-page":"a017863","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1039\/c5md00057b","article-title":"1, 2, 3-Triazole derivatives as antitubercular agents: synthesis, biological evaluation and molecular docking study","volume":"6","author":"Shaikh","year":"2015","journal-title":"MedChemComm"},{"key":"B55","doi-asserted-by":"publisher","first-page":"100102","DOI":"10.1016\/j.ejmcr.2023.100102","article-title":"Synthesis of 2-(6-substituted quinolin-4-yl)-1-(4-aryl-1H-1, 2, 3-triazol-1-yl) propan-2-ol as potential antifungal and antitubercular agents","volume":"7","author":"Shinde","year":"2023","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"22360","DOI":"10.1039\/c3ra44440f","article-title":"Synthesis of biologically as well as industrially important 1,4,5-trisubstituted-1,2,3-triazoles using a highly efficient, green and recyclable DBU\u2013H2O catalytic system","volume":"3","author":"Singh","year":"2013","journal-title":"RSC Adv."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"B58","unstructured":"WHO2020"},{"key":"B59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1073\/pnas.0909133107","article-title":"Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents","volume":"107","author":"Zhou","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1424017\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T07:25:31Z","timestamp":1723015531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2024.1424017\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":60,"alternative-id":["10.3389\/fchem.2024.1424017"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2024.1424017","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"article-number":"1424017"}}